Immix Biopharma Inc (IMMX)
2.340
+0.04
(+1.61%)
USD |
NASDAQ |
Jun 25, 16:00
2.340
0.00 (0.00%)
After-Hours: 20:00
Immix Biopharma Market Cap: 61.81M for June 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 24, 2024 | 60.83M |
| June 21, 2024 | 53.89M |
| June 20, 2024 | 50.72M |
| June 18, 2024 | 53.09M |
| June 17, 2024 | 54.15M |
| June 14, 2024 | 54.41M |
| June 13, 2024 | 54.94M |
| June 12, 2024 | 56.53M |
| June 11, 2024 | 53.89M |
| June 10, 2024 | 54.68M |
| June 07, 2024 | 53.62M |
| June 06, 2024 | 54.41M |
| June 05, 2024 | 54.94M |
| June 04, 2024 | 47.81M |
| June 03, 2024 | 51.51M |
| May 31, 2024 | 55.73M |
| May 30, 2024 | 55.21M |
| May 29, 2024 | 57.58M |
| May 28, 2024 | 61.02M |
| May 24, 2024 | 59.43M |
| May 23, 2024 | 56.00M |
| May 22, 2024 | 56.79M |
| May 21, 2024 | 60.75M |
| May 20, 2024 | 66.56M |
| May 17, 2024 | 65.24M |
| Date | Value |
|---|---|
| May 16, 2024 | 59.43M |
| May 15, 2024 | 62.07M |
| May 14, 2024 | 58.11M |
| May 13, 2024 | 57.05M |
| May 10, 2024 | 57.58M |
| May 09, 2024 | 57.58M |
| May 08, 2024 | 59.15M |
| May 07, 2024 | 58.35M |
| May 06, 2024 | 61.52M |
| May 03, 2024 | 62.05M |
| May 02, 2024 | 60.99M |
| May 01, 2024 | 57.30M |
| April 30, 2024 | 57.30M |
| April 29, 2024 | 55.98M |
| April 26, 2024 | 56.24M |
| April 25, 2024 | 55.45M |
| April 24, 2024 | 56.24M |
| April 23, 2024 | 60.73M |
| April 22, 2024 | 56.24M |
| April 19, 2024 | 57.81M |
| April 18, 2024 | 58.34M |
| April 17, 2024 | 65.99M |
| April 16, 2024 | 67.84M |
| April 15, 2024 | 70.21M |
| April 12, 2024 | 72.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.45M
Minimum
Nov 10 2022
144.43M
Maximum
Dec 15 2023
46.08M
Average
34.08M
Median
Jul 22 2022
Market Cap Benchmarks
| RenovoRx Inc | 26.83M |
| CEL-SCI Corp | 66.62M |
| AIM ImmunoTech Inc | 20.00M |
| IGC Pharma Inc | 27.50M |
| NovaBay Pharmaceuticals Inc | 2.270M |
Market Cap Related Metrics
| Price to Book Value | 2.214 |
| Price | 2.340 |
| Earnings Yield | -39.75% |